Clinical Trial Update: A Phase II Trial of Organoid Drug Sensitivity Testing to Guide Therapy in Unresectable Biliary Tract Cancers [Phase 2]

View source ↗

Summary

A Phase II trial is evaluating organoid drug sensitivity testing to guide therapy for unresectable biliary tract cancers, with the study currently not yet recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Snippet

Sponsor: Eastern Hepatobiliary Surgery Hospital | Conditions: Advanced Biliary Tract Cancer(BTC) | Phase 2 | Status: NOT_YET_RECRUITING